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ABSTRACT: The blood–brain barrier (BBB) consists of endothelial cells, astrocytes, and pericytes embedded in basal
lamina (BL). Most in vitro models use nonhuman, monolayer cultures for therapeutic-delivery studies, relying on
transendothelial electrical resistance (TEER)measurementswithout other tight-junction (TJ) formationparameters.We
aimed to develop reliable, reproducible, in vitro 3-dimensional (3D)models incorporating relevant human, in vivo cell
typesandBLproteins.The3DBBBmodelswereconstructedwithhumanbrainendothelialcells,humanastrocytes,and
human brain pericytes in mono-, co-, and tricultures. TEER was measured in 3D models using a volt/ohmmeter
andcellZscope. InfluenceofBLproteins—laminin, fibronectin,collagentypeIV,agrin,andperlecan—onadhesionand
TEERwas assessed using an electric cell-substrate impedance–sensing system. TJ protein expressionwas assessed by
Westernblotting (WB) and immunocytochemistry (ICC). Perlecan (10mg/ml) evokedunreportedly high, in vitroTEER
values (1200V) and the strongest adhesion.Coculturing endothelial cellswith astrocytes yielded thegreatest resistance
over time. ICC and WB results correlated with resistance levels, with evidence of prominent occludin expression in
cocultures. BL proteins exerted differential effects on TEER,whereas astrocytes in contact yielded higher TEER values
and TJ expression.—Maherally, Z., Fillmore, H. L., Tan, S. L., Tan, S. F., Jassam, S. A., Quack, F. I., Hatherell, K. E.,
Pilkington,G. J. Real-time acquisition of transendothelial electrical resistance in an all-human, in vitro, 3-dimensional,
blood–brain barrier model exemplifies tight-junction integrity. FASEB J. 32, 168–182 (2018). www.fasebj.org
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The blood–brain barrier (BBB) is a dynamic and selective
diffusionbarrier that is highly restrictive in the transport of
substances between the blood and the CNS (1, 2). It also
offers a challenge for the passage of bloodborne cells,
including white blood cells and circulating cancer cells,
entering the brain (3) and is essential for the healthy
functioning of the CNS (2).
The BBB is a complex system composed of various cel-
lular components, including brain endothelial cells lining
the cerebral vasculature (4), a vascular basal lamina (BL),
pericytes embedded within the BL (5), and astrocyte end-
feet ensheathing the vessels (1). These components form
what is termed the functional neurovascular unit (6).
The tight junction (TJ)networkof theBBB is central to its
functional integrity and is composed of a strikingly com-
plex pattern of transmembrane protein expression, in-
cluding junctional adhesion molecules and cytoplasmic
proteins associated with TJs (7, 8).
The BL is an additional and vital component of the
neurovascular unit because it has specific extracellular
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matrix (ECM) molecules that are important for the
maintenance of the BBB (9). Indeed, the ECM, which
composes the BL and is squeezed between endothelial
cells and astrocyte end-feet, has an important role in
maintaining the health and function of vascular endo-
thelial cells. The BL is composed of fibronectin, type IV
collagen, nidogens, laminin, and heparan sulfate proteo-
glycans (agrin and perlecan) (10). These ECMproteins are
vital for the formation and preservation of the BL (11) and
have important roles in cell adhesion, migration, differ-
entiation, and growth (12). Interactions among ECM
proteins and other cells influence various signaling
pathways, which results in increased expression of the
component TJ proteins; therefore, the ECMof the BBB has
an essential role in barrier structural integrity and main-
tenance (13, 14). Collagen IV, laminin, and fibronectin are
major constituents of the neurovascular BL (15), with fi-
bronectin having a strong role in cellular adhesion and
laminin by being involved in the polarization of cells, an
important feature contributing to the BBB properties (15)
and constituting the primary ECM component required
for BL assembly. Collagen IV is also reported to maintain
BL structural integrity (10). Agrin also accumulates ex-
tensively in the BL of the brain microvasculature (16).
Moreover, a role for agrin in BBB development was
highlighted through its accumulation around brain
microvessels during chicken and rat embryonic devel-
opment (17). In parallel, loss of agrinwas seen to correlate
with a loss of junctional protein expression in the cerebral
blood vessels and enhanced BBB leakiness in vivo (18, 19),
supporting its role in BBB maintenance. Perlecan also
appears to have a critical role in basement membrane
maintenance and stability (20, 21). Perlecan is most abun-
dant in the CNS capillary BL, interacting with other com-
ponents of the BL and several growth factors, suggesting
it has a role in the formation and stabilization of the BL
(20, 22). Deguchi et al. (23) suggested that perlecan has an
important role inBBBfunctionviagrowth factor regulation,
such as fibroblast growth factor, a soluble factor that is
likely essential for maintaining BBB integrity.
The cellular components comprising the BBB and the
constituents aiding its structure act in concert for it to retain
its dynamic functions. Although complex, the need to de-
velop invitromodels that includesuch invivo components/
constituents will aid in the discovery of how putative
therapeutic agents pass through the BBB, and the un-
derlying mechanisms by which cancer cells from other re-
gions of the body can metastasize to the brain.
There are few reliable, in vitro models of the BBB (24);
however, althoughnotdirectly replacing in vivomodels, in
vitromodels can be improved. The current gold standard
method used to measure BBB integrity is transendothelial
electrical resistance (TEER) and transendothelial perme-
ability coefficient for small, soluble, inert tracers (25).
Many research groups use nonhuman animals or
animal cells to construct BBB models with which to
explore cerebral metastasis and delivery of drugs for
brain pathologies. Animal models are often considered
a more attractive prospect for researchers than human
models because access to human components is chal-
lenging and higher costs are involved (e.g., human
serumsupplementation).However, animalmodels,both in
vitro and in vivo, containmany apparent protein/antigenic
and gene/molecular differences compared with human
tissues and models.
To address this concept and circumvent the continued
use of nonhuman animal models that may not accurately
reflect the human brain and/or the disease under in-
vestigation, it is essential to develop and demonstrate the
effective utility of reproducible, 3-dimensional (3D), all-
human, in vitro models that incorporate human cells and
ECM components under human serum supplementation
conditions. Such models will better simulate the in vivo
human situation for use in studies of disease pathogenesis
and treatment-delivery modalities.
MATERIALS AND METHODS
Cells
Human cerebral microvascular endothelial cell line D3
(hCMEC/D3) cells, immortalized with hTERT catalytic sub-
units and simian vacuolating virus 40 large T antigens (26),
were donated byDr. Pierre-Olivier Couraud (Institut Cochin,
INSERM, Paris, France). Human, healthy, cerebral cortex–
derived astrocytes (line SC-1800) and human brain vascular
pericytes (HBVPs) were purchased from Caltag Medsystems
(Buckingham, United Kingdom). hCMEC/D3 cells were grown
in endothelial basal medium 2 (Lonza, Basel Switzerland) sup-
plemented with SingleQuots (Lonza) and 2% human serum
(Sigma-Aldrich, St. Louis, MO, USA). SC-1800 were grown in
astrocyte basal medium (AGM; Lonza) supplemented with Sin-
gleQuots (Lonza) and 3% human serum (Sigma-Aldrich). HBVP
were cultured in pericyte basal medium (Caltag Medsystems),
supplementedwith pericyte growth factors (CaltagMedsystems)
and 2% human serum (Sigma-Aldrich). All cells were grown in a
5% CO2 atmosphere, 37°C incubator. Cell lines were authenti-
cated as human with a microfluidic electrophoresis system in-
corporating a 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA, USA) to analyze short tandem repeat PCR fragments
from 10 human genomic loci of human cell lines (27). Cells were
routinely tested for mycoplasma with a kit from Lonza.
ECM concentrations
The following ECMs were used in the model, based on the
manufacturer’s recommended working range: recombinant hu-
man endorepellin/perlecan (R&D Systems, Minneapolis, MN,
USA) at 2.5–10 mg/ml, recombinant human agrin (R&D Sys-
tems) at 1–3.5mg/ml, humancollagen type IV (Sigma-Aldrich) at
7–10 mg/ml, laminin from a coculture system of human fibro-
blasts and epithelial cells that contains the laminin subunit b 1
(Sigma-Aldrich) at 25–75 mg/ml, and fibronectin from human
plasma (Sigma-Aldrich) at 1–5 mg/ml.
Antibodies
Primary antibodies
The following antibodies were used: rabbit pAb, IgG, anti–von
Willebrand factor (vWF) at 1:100 for immunocytochemistry
(ICC); 1:20 for flow cytometry (FC; Abcam, Cambridge, MA,
USA), mousemAb, IgG1, anti–platelet endothelial cell adhesion
molecule-1 (PECAM-1, 1:200; 1:20; Abcam), rabbit mAb, IgG,
anti-b catenin (1:250; 1:10) (Abcam), rabbit pAb, IgG, anti–a-
smoothmuscleactin (SMA,1:100; 1:20;Abcam), rabbitpAb, IgG,
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anti–glial fibrillaryacidicprotein (GFAP; 1:200; 1:25), andmouse
mAb, IgG, anti-vimentin (1:500; 1:25; Agilent Technologies) and
mouse mAb, IgG, anti-chondroitin sulfate (NG2, 1:500; 1:25;
R&D Systems). Rabbit pAb, IgG, anti-occludin (1:200; Abcam)
was used for ICC andWestern blot (WB). Rabbit pAb, IgG, and
anti-cyclophilin A (Abcam) were used as a loading control for
WB at 1:10,000.
Secondary antibodies
Fluorochrome-conjugated AlexaFluor-488 and -568 (Thermo
Fisher Scientific, Waltham, MA, USA) were used in ICC and FC
(1:500). Horseradish peroxidase–conjugated IgG (Thermo Fisher
Scientific) was used for chemiluminescent detection in WB
(1:1000).
Cytopainter dyes
A CytoPainter cell tracking staining kit (Abcam) was used to
uniformly label live cells per the manufacturer’s instructions for
investigating TJ protein expression in co- and triculture BBB
models. Before seeding for subsequent BBB experiments, 13 106
endothelial cells were dyed green, astrocyteswere dyed red, and
pericytes were dyed blue.
Cell proliferation assay
CellTiter 96 Aqueous One Solution cell proliferation assay kit
(Promega, Madison, WI, USA) also known as 3-(4,5-dimethyl-
thiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium, inner salt (MTS), was used to assess the
proliferation rate of the cells, according to the manufacturer’s
protocol. Briefly, hCMEC/D3 cells were seeded at 2.5 3 104,
5.0 3 104, 7.53 104, and 1.5 3 105 cells/well and incubated at
37°C, 5% CO2 for 5 d. Subsequently, every 24 h, 20 ml of MTS
reagent was added to each well, and cells were incubated fur-
ther for 3 h at 37°C, 5% CO2, before being read on a spectro-
photometermicroplate reader (PolarstarOptima; BMGLabtech,
Ortenberg, Germany). Absorbance values were recorded at
490 nm. Each experiment was repeated 3 times in triplicate. A
standard curve was previously calibrated at cell densities of
2.53 104, 5.03104, 7.53 104, 1.03105, and 1.53 105 cells/well.
Cell viability assay
Quantitative analysis of viable cells was investigated using the
Trypan blue exclusion method, which is based on the principle
that the suspension of hCMEC/D3 cells is simply mixed with
Trypan blue, then automatically visualized and counted by the
Vi-Cell Analyzer using the Vi-Cell XR software (Beckman
Coulter, Brea, CA, USA). In that protocol, only nonviable cells
take up the dye. Before harvesting cells, the confluency level was
visualizedwithanOlympus (Tokyo, Japan) 1X71 invertedphase-
contrast microscope.
ICC
ICC was performed following an established, previously de-
scribed procedure (28). Briefly, cells were seeded onto sterile
coverslips within a 6-well plate at 1 3 105 cells/well, fixed with
4% paraformaldehyde (Sigma-Aldrich) and permeabilized with
0.1% Triton X-100 (Sigma-Aldrich) for intracellular antigen de-
tection, before incubation with the primary antibody. Cells were
then incubatedwith the relevant secondary antibody. Cells were
washed with 13 PBS before and after antibody incubation. Nu-
cleiwere counterstainedwithHoechst Blue (Sigma-Aldrich), and
slides viewed using an Axio Imager Z1 fluorescence microscope
(Carl Zeiss, Oberkochen, Germany). Images were captured with
Volocity image analysis software (v.5.2; PerkinElmer, Waltham,
MA, USA).
FC
FC was performed using standard protocols (28). Cells were
seeded in 6-well plates at 2 3 105 cells/well. For intracellular
antigen staining, cells were permeabilized with cytofix/
cytoperm solution (BD Biosciences, Franklin Lakes, NJ, USA)
and blocked in 2% serum/0.2% saporin/PBS (Sigma-Aldrich)
before primary antibody incubation, then washed with 0.2%
saporin/PBS and incubated with secondary antibodies. After
incubation, cells were washed, resuspended in PBS, then trans-
ferred to fluorescence-activated cell sorting tubes (BD Biosci-
ences). Propidiumiodide (Sigma-Aldrich)wasadded to samples
to ensure viability of cells, except for intracellular antigen de-
tection. Analysis was performed on a 4-color, multiparameter,
fluorescence-activated cell sorter (Calibur; BD Biosciences),
equippedwith a 488-nmargon gas laser and a 635-nm red diode
laser. Each sample was analyzed in triplicate plus 1 negative
control (primary antibody omitted and isotype control IgG
used), and the experiment was repeated 3 times. The expression
level was assessed by the percentage of positive cell population.
WB
Cell lysates were separated in the any-kilodalton precast SDS-
PAGE gel (Bio-Rad Laboratories, Hercules, CA, USA) and
transblotted onto a PVDF membrane (GE Healthcare Life
Sciences, Little Chalfont, United Kingdom). Immunodetection
was achieved using the primary antibodies and horseradish
peroxidase–conjugated secondary antibodies. The blot was then
visualized and analyzed with the Gbox Chemi XT16 system
(SynOptics Communications, Santa Clara, CA, USA). Cells not
coated with any ECMwere used as controls.
Confocal microscopy
ICC imageswerecapturedusing the340oil-immersionobjective
of a Zeiss meta LSM 510 Axioskop2 confocal microscope. Fluo-
rescence was detected at excitation wavelengths of 488 (green),
568 (red), and 405 nm (blue), with argon, HeNe1, and diode
lasers, respectively. Multitrack image capture was used with 2
channels so that separate channels could imagedifferent colors to
help prevent any overlap in excitation spectra. Identical settings
were then used to image negative controls in which the primary
antibody was omitted.
Adhesion assays
Quantitative adhesion assay
Plates (96 wells; Greiner Bio-One, Frickenhausen, Germany)
were coated with recombinant human endorepellin/perlecan
(R&D Systems) at 2.5–10 mg/ml, recombinant human agrin
(R&DSystems) at 1–3.5mg/ml, human collagen type IV (Sigma-
Aldrich) at 7–10mg/ml, laminin fromhuman fibroblasts (Sigma-
Aldrich) at 25–75 mg/ml, or fibronectin from human plasma
(Sigma-Aldrich) at 1–5mg/ml and incubated at 37°C, 5%CO2 for
2 h. Cells at a density of 7.5 3 104 cells/well were seeded onto
each of the above substrates. The platewas then incubated for 2 h
at 37°C in a CO2 incubator. Subsequently, unbound cells were
vigorouslywashedawaywithPBS, andadherent cellswere fixed
with 4% PBS and stained with crystal violet (0.1% w/v; Sigma-
Aldrich). Absorbance of stained nuclei was determined using a
plate reader (Polarstar Optima) at 570 nm. All tests were per-
formed in triplicate and repeated 3 times.
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Qualitative adhesion assay
hCMEC/D3 cells were labeled with Cytotracker solution for 1 h
at 37°C and seeded onto precoated (with optimized differential
ECMs) coverslips at a density of 1 3 106/well and grown to
confluency. After 3 h incubation at 37°C, cells werewashedwith
PBS, fixedwith 4%paraformaldehyde, and stainedwithHoechst
blue. Coverslipsweremounted onto slideswith Vectashield and
viewed under a fluorescence microscope (Axio Imager Z1).
Analysis was performed using the Volocity software.
Resistance monitoring with electric cell substrate
impedance sensing
Electric cell substrate-impedance sensing (ECIS) arrays
(8W10E+, 8 wells; ibidi, Planegg, Germany) were stabilized
with L-cysteine (10 nM, 10 min), washed in HBSS (Thermo
Fisher Scientific), and coated with recombinant human
endorepellin/perlecan at 2.5–10 mg/ml, recombinant human
agrin at 1–3.5 mg/ml, human collagen type IV at 7–10 mg/ml,
human fibroblast laminin at 25–75 mg/ml, or human plasma
fibronectin at 1–5 mg/ml and incubated at 37°C, 5%CO2 for 2 h.
Cells (7.5 3 104 after seeding-density optimization) were then
seeded into each chamber, and cell resistance was monitored at
4000Hz using an ECIS Zu (Applied Biophysics, Troy, NY, USA)
system for 160 h at 37°C with 5% CO2. Resistance values were
obtained in ohms.
In vitro, human BBB models
Mono-, co-, and triculture BBB models were constructed using
hCMEC/D3 cells, SC-1800 astrocytes, and HBVPs. Polycar-
bonate membrane transwell inserts (24-well tissue cultures,
8-mm porosity; Corning, Corning, NY, USA) were coated with
10mg/ml human perlecan (R&DSystems) on the apical side and
5 mg/ml human fibronectin (Sigma-Aldrich) on the basal side of
the filter. The cell-seeding density for SC-1800 cells and HBVPs
was 2.5 3 104/filter and for hCMEC/D3, 7.5 3 104 cells/filter.
Depending upon culture combination/setup, SC-1800 cells and
HBVPswere seeded on the basal side of the porous filter and left
to adhere for 2 h before incubating for 72 h at 37°C, 5% CO2.
hCMEC/D3cellswere then seeded on the apical side of the filter,
and TEER measurements were read using both the epithelial
volt-ohmmeter (EVOM;World Precision Instruments, Sarasota,
FL, USA), according to the manufacturer’s instructions and the
automated cell monitoring CellZscope system (NanoAnalytics,
Mu¨nster, Germany). EVOM resistance values were measured
manually every 5–8 h/d for 160 h, and Ohm’s law was applied.
The CellZscope system provides noninvasive, continuous mon-
itoring of cell monolayers, measuring contact line capacitance
(Ccl) as well as resistance, thus rendering a 3D approach to BBB
monitoring. In this study,weplaced the tissue culture inserts into
a 24-well cell module, and the system was incubated (37°C and
5% CO2); TEER values, expressed in ohm square centimeters,
were recorded in real time every hour. High TEER values
reflected tight barriers. ElectricalCclwas also recorded tovalidate
TEER values. For each experiment, at least 3 replicates were
measured. Results are expressed as means6 SEM.
TEER measurements
TEER values obtained in ohm square centimeters using cellZ-
scope cannot be compared directly to measurements using dif-
ferent instruments, such as the ECIS system (V) or EVOM
(V/cm2) because the parameters, such as the height and the
surface area of the inserts, along with the AC frequencies for
TEER measurements, differ. With the traditional, chopstick-
electrodemethod, AC current is passed, the voltage ismeasured,
and Ohm’s law is applied to calculate the resistance of the
monolayer; that system is deemed unreliable because it depends
on the position and angle of electrode placement. In the ECIS
system, there is no basolateral side because the cells are plated
onto the electrode wells, which then need mathematical nor-
malization of the variables mentioned before the TEER can be
regarded as a true absolute measure.
Resistance monitoring using xCelligence
Anadditional system, xCelligence (ACEABiosciences, SanDiego,
CA,USA),wasused as a comparator to the 3 former systemsused
routinely in our laboratories. In this study, mono, co-, and tri-
culture BBBmodelswere set upusing theCell InvasionMigration
plate 16 and 8-mm porosity membrane (Roche Diagnostics, Indi-
anapolis, IN, USA). The cell-seeding density for SC-1800 cells and
HBVPswas2.53104/filterand7.53104cells/filter forhCMEC/D3
cells. Depending on the culture combination/setup, SC-1800 cells
and HBVPs were seeded on the basal side of the porous filter
membrane and left to adhere for 2 h before incubating for 72 h at
37°C,5%CO2.hCMEC/D3cellswere then seededon theapical side
of the filter. The plates were then assembled according the manu-
facturer’s instructions and connected to the xCelligence DP system.
Valueswere expressed as the cell index equating to resistance levels.
For each experiment, at least 3 replicates were measured.
Statistical analysis
All experiments were performed 3 times independently in trip-
licate, unless otherwise stated. All values reported are means 6
SEM, unless otherwise stated. Statistical analysis was performed
using 1-wayANOVA, followedbyTukey’smultiple comparison
post hoc tests, with a probability of P , 0.05 regarded as signifi-
cant. The software package Prism (v.6.05; GraphPad Software,
La Jolla, CA, USA) was used.
RESULTS
Todevelop the 3Dmodels,we first established the optimal
endothelial cell density for obtaining high TEER values,
with a goal of being able to reach high resistance values
within a reasonable time and for that to be maintained for
20 h to enable testing of compounds crossing the barrier.
We therefore conducted several optimization experiments
in 2D format using hCMEC/D3 cells.
Characterization of cultured endothelial cells
Established endothelial markers—vWF and PECAM-1
(Fig. 1)—were assessed by ICC and FC. Cytoplasmic
granular expression of vWF was evenly distributed over
the cells, whereas PECAM-1 was widely distributed over
the cells but condensed on the leading membrane. FC ex-
pression levels of the above-mentioned antigens were
60.92 and 98.98%, respectively (Fig. 1, bottom).
Endothelial seeding densities and TEER
hCMEC/D3 cells were seeded at increasing densities
from 2.5 3 104 to 1.5 3 105 cells/cm2, and resistance was
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recorded for 160 h using ECIS (Fig. 2A). The optimal
starting seeding density was determined to be 7.5 3 104
cells/cm2. At that density, the greatest resistance reached
was 920 V, achieved at 60 h, where values were main-
tained above 850 V for ;20 h (Fig. 2A). Phase-contrast
images demonstrated that hCMEC/D3 cells formed
monolayers at the 60-h point (Fig. 2B) anddid not clump.
In parallel, the proliferation assay (Supplemental Fig. 1)
demonstrated that, at 48–72 h, there was no evidence
of proliferation (represented by the constant values/
plateau) (red box) supporting the resistance obtained in
Fig. 2A.
Perlecan and agrin are the most effective BLs
in increasing TEER and endothelial adhesion
The next step was to examine the effect of individual
BLmolecules onhCMEC/D3 cell adhesion and resistance
in a 2-D setting to determine optimal ECMconcentrations
for use in downstream 3D BBB experiments. Five BL
molecules, based on the existing literature regarding
CNS BBB, were selected: fibronectin, laminin, collagen
IV, agrin, and perlecan. Increasing concentrations of
individual ECM components were used to coat wells,
followed by the addition of hCMEC/D3 cells (7.53 104
cells/cm2). hCMEC/D3 cell adhesion to individual
ECMs was analyzed quantitatively using a crystal vio-
let adhesion assay.
There was an increase in endothelial cell adhesion
with increasing concentrations of fibronectin (5 mg/ml),
laminin (75 mg/ml), collagen IV (10 mg/ml), and
perlecan (10 mg/ml) (Fig. 3). Interestingly, the highest
concentration of agrin did not correspond to an in-
crease in endothelial cell adhesion; only 1 mg/ml was
needed to achieve the highest adhesion (56.2%) (P ,
0.001) (Fig. 3). In general, adhesion correlated with
increased resistance and greater concentrations of in-
dividual BL molecules.
Using the optimal BL components, we performed par-
allel experiments examining resistance, cell adhesion, vi-
ability, andmotility. Thehighest TEERvalueswere seen in
endothelial cells plated on 10 mg/ml perlecan (1200 V),
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Figure 1. ICC (top) and FC (bottom) showing expression of vWF (A) to identify cytoplasmic granules, which were present in
endothelium and were expressed at 60.92%, and PECAM-1 (B) to identify cellular junction-associated proteins, which were
expressed at 98.98% (n = 3). Scale bars, 20 mm. For FC, the green graph shows the control (no primary antibody added; isotype
controls were used), and the pink graph demonstrates positive expression of previously-mentioned antigens.
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followed by 1 mg/ml agrin (980 V), 5 mg/ml fibronectin
(620 V), 10 mg/ml collagen IV (600 V), 75 mg/ml lam-
inin (580V), and the control (no BL) at 500V (Fig. 4A) at
60 h (P, 0.0001). Under the same conditions, and at the
60-h point, phase-contrast images indicated that endo-
thelial cells seeded on each optimized BL formed a
monolayer and contributed to increased resistance
(Fig. 4B). Those results were in agreement with the
quantitative adhesion assay, which demonstrated
that the highest adhesion potential was reachedwhen
endothelial cells were seeded onto perlecan, followed
by agrin, fibronectin, laminin, collagen IV, and the
control (no ECM) (P , 0.01) (Fig. 4C). The viability of
cells was assessed using a trypan blue exclusionmethod
over time to determine whether viability of endothelial
cells was compromised after BL coating. Results con-
firmed that there was no effect on the viability of cells
(Fig. 4D). Themotility assaydatawere in agreementwith
the adhesion results (Fig. 4C). Cells traveled fastest and
furthest under no-ECM coating (n = 30; P , 0.05) (Fig.
4E). Highest expression of occludin was observed when
endothelial cells were seeded on perlecan and agrin
(Supplemental Fig. 2), suggesting an increase in TJ
formation, supporting the resistance values obtained in
Fig. 4A.
Characterization of astrocytes and pericytes
For our next step in 3D model development, we in-
corporated the use of SC-1800 astrocytes and HBVPs
with the hCMEC/D3 cells as described. ICC and FC
were conducted using specific known markers to con-
firm their lineage (Fig. 5). SC-1800 cells expressedGFAP
and vimentin at 78.50 and 57.90%, respectively. ICC
results demonstrated thread-like staining of GFAP,
with an even distribution extending through the cell
processes, whereas vimentin showed filamentous dense
staining within cell processes (Fig. 5A). HBVPs expressed
a-SMA andNG2 at 66.50 and 68.30%, respectively. ICC
results showed granular expression of a-SMA with a
slightly denser expression at process terminals while a
relatively even, granular distribution of NG2 was seen
(Fig. 5B).
Astrocytes and pericytes enhance TEER
The next part of the project was to employ the 3D, “all-
human,” in vitro, BBB model for different functional
screening technologies to assess the TEER, includ-
ing EVOM, the cell automated monitoring system,
CellZscope, and xCelligence with different variations
of the BBB models (mono-, co-, and triculture combi-
nations). The hCMEC/D3 cells, SC-1800 astrocytes,
and HBVPs under human serum supplementation
were used in different coculture conditions, and the
effect on barrier tightness through resistance readouts
were compared when cells were in or out of contact
in various culture combinations using the EVOM
(Fig. 6A) and only with in-contact simulations using
cellZscope (Fig. 6B). In those experimental designs,
10mg/ml of perlecan (previously optimized) was used
to precoat wells before seeding. TEER values were
obtained over 170 h using the EVOM (Fig. 7A).
The optimal TEER value was reached between 80 and
120 h using the endothelial cell in-contact paradigm
with astrocytes alone, with TEER values peaking to
450 V/cm2 at 100 h, followed by out-of-contact cocul-
tures of endotheilal cells + astrocytes (E + A) (385 V/cm2)
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Figure 2. A) Optimal seeding density of hCMEC/D3 cells using ECIS. The optimal seeding density of hCMEC/D3 cells was 7.5 3
104 cells/well, based on the highest TEER value (920 V) observed at 60 h. B) Morphologic analysis of hCMEC/D3 cells imaged
using a phase-contrast microscope at 60 h. Results show a conﬂuent monolayer that correlated with highest TEER values reached
in A. Scale bar, 20 mm.
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and in-contact triculture of endotheilal cells + astrocytes +
pericytes (E + A + P) at 375 V/cm2. Monoculture of en-
dothelial cells alone generated a peak in TEER at 258
V/cm2 at 100 h. The in-contact paradigm resulted in an
enhancement of TEER values.
Similar results were obtained when mono-, co-, and
triculture models were constructed and their resistance
recorded by cellZscope (Fig. 7B, top). Results showed
greatest resistancewas reachedwhen cells were grown in
cocultures of E + A (27 V · cm2) at 80 h, followed by
tricultures of E + A + P at 22 V · cm2. Monocultures of
endothelial cells alone generated a peak at 85 h with
resistance at 13.5V · cm2. ElectricalCcl valueswere also
recorded (Fig. 7B, bottom), and results showed re-
sistance values increased andCcl decreased, validating
the resistance values obtained.
Similar trends were observed via the xCelligence sys-
tem (Supplemental Fig. 3), which produced highest cell
index (equating to resistance values) at 3.0with cocultures
of E + A.
TJ protein expression mirrored TEER
Occludin, b-catenin, and zonula occludens-1 (ZO-1)
protein expression, as seen in WB analyses, correlated
with resistance measurements. Occludin, b-catenin,
and ZO-1 expressions were increased in cocultures of
E + A compared to the other culture conditions and
when controlled for cyclophilin A (Fig. 8A). Semi-
quantitative WB analysis demonstrated that, when com-
pared to endothelial cells alone, occludin, b-catenin,
and ZO-1 immunoreactivity were greatest with a relative
density of 1.6, 1.18, and 1.54 in cocultures of E + A
(P , 0.0001) followed by tricultures of E + A + P (Fig.
8B). ICC results were in agreement with WB analysis,
which showed greatest occludin expression (white) in
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Figure 3. Adhesion of hCMEC/D3 cells at 60 h for ﬁbronectin (A) at 1–5 mg/ml, laminin (B) at 25–75 mg/ml, collagen type
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174 Vol. 32 January 2018 MAHERALLY ET AL.The FASEB Journal x www.fasebj.org
Downloaded from www.fasebj.org by (148.197.97.45) on May 01, 2018. The FASEB Journal Vol. 32, No. 1, pp. 168-182.
cocultures of E + A compared with mono- and tricultures
(Fig. 8C).
BBB integrity was maintained in
model systems
Additional experiments were conducted to confirm
BBB integrity. Evans bluewas added to various culture
configurations, and resistance was measured using
EVOM. After coculture of E + A, simulation reached a
maximum resistance at 410 V/cm2 at 90 h. Resistance
was recorded with EVOM after the addition of Evans
blue for 24 h. Results showed that Evans blue did not
cause any significant effect on the resistance values,
suggesting barrier integrity was maintained (P ,
0.001) (Fig. 9).
DISCUSSION
Themajor goal of this studywas todevelop a reproducible
and reliable, in vitro, BBB model that included cell types
and components to better reflect the in vivo situationwhen
comparedwith existing publishedmodels.We also aimed
to ensure that thismodelmaintained a reproducible, intact
barrier toadequately test the abilityof therapeutics to cross
the BBB. It was thus felt to be essential to use human cells
and human serum.
Figure 4. A) Resistance with various optimized ECMs. The highest TEER value was reached by coating wells with 10 mg/ml
perlecan (1200 V), followed by 1 mg/ml agrin (980 V), 5 mg/ml ﬁbronectin (620 V), 10 mg/ml collagen IV (600 V), 75 mg/ml
laminin (580 V), and the control (no ECM) at 500 V. B) Phase-contrast images show conﬂuency of hCMEC/D3 cells
under brightﬁeld microscopy. Results show that hCMEC/D3 cells adhered best on perlecan. C) Quantitative adhesion of
hCMEC/D3 cells achieved under various ECMs. Ranking of the highest adhesion potential occurred with endothelial cells
seeded onto similar concentrations as in A: perlecan, agrin, ﬁbronectin, laminin, collagen IV, and control (no ECM). D)
Viability of hCMEC/D3 cells under different ECMs. Results show the viability of cells was not affected when treated with different
ECMs. E) Motility of hCMEC/D3 cells under different ECMs. Cells traveled fastest and furthest under no ECM [n = 3 (A, C); n = 30
(E)]. *P , 0.05, **P , 0.01, ****P , 0.0001. Scale bars, 20 mm.
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We confirmed the cells used were of human origin (by
DNA fingerprinting) and that they were indeed endothe-
lial cells, astrocytes, and pericytes (as analyzed by both
ICC and FC). Positive ICC expression was gained for all
target proteins investigated; vWF and PECAM-1 for
hCMEC/D3 cells, GFAP and vimentin for SC-1800
astrocytes, and a-SMA and NG2 for HBVPs.
vWF and PECAM-1 (CD31) were selected as markers
because of their specific expression in brain endothelial
cells (26, 29, 30), andGFAP and vimentinwere selected as
astrocyte markers (31–33). There is, at present, no anti-
genic marker available for all pericytes within the body
because of their diverse characteristics and range of
functions in a variety of organs (34). However, because of
their contractile nature, the presence of a-SMA is fre-
quently evidenced onhumanvascular pericytes.NG2has
also been shown to be expressed on pericyte cell surfaces
during angiogenesis and other vascular processes (34).
Indeed, expression of both a-SMA and NG2 has been
found to be unique characteristics of pericytes located in
neural tissue; thus, theirpositiveexpressionconfirmed the
authenticity of HBVPs (35).
Little has been reported on BL components and their
influence on human brain endothelial cell and BBB in-
tegrity in vitro. In particular, information gained in the
present study concerning agrin and perlecan and their
influenceonhumanbrainendothelial cells in this context is
novel. Our data showing the influence of agrin and per-
lecanonBBB integrity do, in fact, correlatewithpreviously
published reports in situ/in vivo (18, 20). It was reported
that the heparan sulfate proteoglycan agrin, which is
expressed in the astroglial basement membrane (36, 37),
stabilizes the junctional localization of the TJ proteins
VE-cadherin, b-catenin, and ZO-1 in mouse brain endo-
thelial cells in vitro (38). Further reports show that agrin
expression correlated with BBB development and main-
tenance (39). In parallel, loss of agrin, followedby loss of TJ
molecules in endothelial cells of human patients with gli-
oma indicated a direct correlation between the presence of
agrin and BBB integrity (18). Agrin is also known as a
major binding protein for a-dystroglycan, which suggests
an involvement in anchoring endothelial cells and astro-
cytes to the BL (40).
Perlecan, another heparan sulfate expressed by as-
trocytes [Winkler et al. (41)], has an important role in BL
maintenance and stability (11). Perlecan also serves as a
signaling platform within the BBB by providing proper
cell–cell interaction, which occurs via binding to, and
signal through, integrin and dystroglycan receptors
located on both endothelial cells and astrocytes (42).
Previous studies also showed that a lack of perlecan in
vivo led to disrupted BL and even death in transgenic
mice (20, 43, 44). Thus, we have provided an accurate
human in vitro system, which mirrors mouse-based in
vivo findings. In our model, perlecan and agrin, as op-
posed to other commonly used ECM molecules, were
superior in obtaining high TEER values as well as high
endothelial cell adherence, which suggests that both
perlecan and agrin expressionmay be under the control
of endothelial/astrocyte interactions.
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Figure 5. Cells used to construct the BBB model assessed by ICC (top) and FC (bottom). A) Astrocyte markers GFAP (right) and
vimentin (left). Thread-like staining of GFAP with an even distribution extending through the cell processes. Vimentin showed
ﬁlamentous staining, denser toward the cell processes. Flow results show expression of GFAP and vimentin to be 78.50 and
57.90%, respectively. B) Pericyte markers a-SMA (left) and NG2 (right). ICC results show granular expression of a-SMA with a
slightly denser expression around the base of the process. A relatively even granular distribution of NG2 was seen. Flow results
show expression of a-SMA and NG2 to be 66.50 and 68.30%, respectively (n = 3). Scale bars, 20 mm. For FC, the red graph shows
the control (no primary antibody was added; isotype controls were used); the blue, pink, and green graphs demonstrate positive
expression of above-mentioned antigens.
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Figure 6. A) In vitro, all-human, BBB model based on mono-, co-, tricultivation transwell layout for in- and out-of-contact simulations.
hCMEC/D3 cells grown as a monoculture, hCMEC/D3 and SC-1800 cells or hCMEC/D3 cells and HBVPs as a coculutre, and
hCMEC/D3 cells, SC-1800 cells, and HBVPs as a triculture. B) Schematic assembly of BBB model. a) Twenty-four-well format, 8-mm
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Upon validating our 3D BBB model, we observed that
coculturing endothelial cells and astrocytes and in-contact
simulation produced the highest resistance compared
with other culture configurations. These findings were
consistent in all 4 technologies usedwithin the scope of the
study, namely, EVOM, ECIS, cellZscope, and xCelligence.
pore size, polycarbonate membrane transwell inserts used. b) Both sides of the ﬁlters were coated with 10 mg/ml perlecan and left to
absorb the EMC for 1 h in the hood. c) Depending on culture combinations, astrocytes or pericytes or both were seeded at 2.5 3 104
cells/insert on the lower side of the ﬁlters with a positive meniscus and left to adhere for 1–2 h in the hood. d, e) Inserts were inverted
were inverted and placed in the plate containing 600 ml medium and left to incubate for 72 h at 37°C. f) hCMEC/D3 cells at 2.53 104
cells/insert were then seeded on the top side of the ﬁlter. g) The combination setup was then placed in the incubator and connected
to a CellZscope instrument to read resistance values.
Figure 7. A) Mono-, co-,
and triculture models con-
structed using 8-mm pore
size polycarbonate-membrane
ﬁlters within 24-transwell
inserts, using both in- and
out-of-contact cell combi-
nations, and their resis-
tance was evaluated by
measuring TEER values
with EVOM. Results show
the highest resistance was
reached when cells were
grown in coculture and in
contact (E + A, endothelial
cells + astrocytes; 450V/cm2)
at 100 h, followed by out-of-
contact coculture (E + A) at
385 V/cm2 and in-contact
triculture (E + A + P, endo-
thelial cells + astrocytes +
pericytes) at 375 V/cm2. B)
Mono-, co-, and triculture
models were constructed
using 8-mm pore size, poly-
carbonate, 24-well plate, trans-
well inserts precoated with
10 mg/ml of perlecan, and
their resistance was evalu-
ated by measuring TEER
values (top) and Ccl (bot-
tom) using cellZscope. Re-
sults show highest resistance
was reached when cells were
grown in coculture (EA, en-
dothelial cells + astrocytes;
27 V·cm2) at 80 h, followed
by triculture (EAP, endothelial
cells + astrocytes + pericytes) at
22 V·cm2 (top). Results show
that as the resistance increases,
the Ccl decreases, validating
cell attachment and spread-
ing (bottom). EP, endothelial
cells + pericytes; E, endothe-
lial cells only; AP, astroctes +
pericytes.
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These findings are supported by both human (45) and
animal (25, 46–48) studies where co- and tricultivation
of astrocytes and/or pericytes with endothelial cells,
significantly increases the tightness of endothelial mono-
layers. In our previously published studies, we confirmed
the coculture model permutation of endothelial cells and
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Figure 8. Expression of the TJ proteins occludin, b-catenin, and ZO-1, depicting tightest junction formation when endothelial
cells were cocultured with astrocytes. A) WB of proteins from BBB culture combinations seeded onto 10 mg/ml perlecan.
E, endothelial cells alone; EA, endotheilal cells + astrocytes; EAP, endothelial cells + astrocytes + pericytes; EP, endothelial cells +
pericytes. B) Semiquantitative analysis using densitometry from A showed the highest occludin, b-catenin, and ZO-1 expression
(59, 87, and 194 kDa) was seen in coculture (EA), followed by triculture (EAP), monoculture (E), and coculture (EP).
Cyclophilin A was used as a protein-loading control (n = 3). ****P , 0.0001. C) ICC images show prominent occludin expression
(white) when cells were cocultured (E + A) compared with the other culture setups. The results conﬁrmed our ﬁndings in Fig. 7A, B.
Cells were stained with cytopaint dyes as follows: endothelial cells (green), astrocytes (red), and pericytes (blue). Scale bars, 20 mm.
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astrocytes was most effective in enhancing barrier prop-
erties (45). In this article, we showed that coculturing en-
dothelial cells with astrocytes in contact produced the
highest TEER value, suggesting that endothelial cells re-
spond positively to the soluble factors produced by as-
trocytes, which corresponds to the in vivo situation. This
finding concurs with those of previous studies which
highlighted that direct contact of endothelial cells with
astrocytes in cocultures induced expression of BBB spe-
cific phenotypes in cocultivation such as increased mito-
chondrial number and increasedTEER (4, 49).Kacem et al.
(50) also reported through previous anatomic examina-
tion of brain microvasculature, that end-feet of astrocytes
form a lacework of fine lamellae to closely support the
outer surfaces of the endothelium. Studies that in-
vestigated coculturing bovine endothelial cells and as-
trocytes on the upper and lower surfaces of a membrane
showed reduced permeability and increased TJ-like
structures characteristic of the BBB in vivo (51). Further
reports have also highlighted the positive influence of glia
on induction of BBBpropertieswhen endothelial cells and
astrocytes were cultured in contact (4). Moreover, Garcia
et al. (52) showed that coculturing endothelial cells with
astrocytes in a cell–cell contact schema increased TJ pro-
teins, such as occludin, and up-regulated P-glycoprotein
on endothelial cells. More recently, Yamamizu et al. (53)
demonstrated enhanced TEER values when coculturing
human-induced pluripotent stem cells differentiated into
culturally induced brain endothelial cells with astrocytes
compared with endothelial cells alone.
For the addition of a third cell type in ourmodel, unlike
other previous studies, in which incorporation of pericytes
in BBB cultures yielded higher TEER values (46), ours
did not. In fact, adding pericytes to our cultures led to a
decrease in resistance in our human models. Our BBB
simulation of triculturing endothelial cells, astrocytes, and
pericytes produceda lowerTEERvalue comparedwith the
coculture arrangement of endothelial cells and astrocytes
alone. There may be several explanations why pericytes
had a negative effect on the formation of TJs in this model.
Similar results have been obtained in previous studies,
which suggest that pericytesmay act as a barrier, stopping
soluble astrocyte factors from reaching endothelial cells
(45). The presence of pericytes may trigger matrix metal-
loprotease (MMP) production throughTNF-a, TGF-b, and
IL-6. As MMPs have been shown to contribute to BBB
regulation via the ECM, increased or overexpression of
MMPs may result in BBB disruption (54). Alternatively,
pericytes, which are highly motile cells and are frequently
seen onnonperivascular locationswithin the brain,may, in
our 3D in vitro systems display anchorage differences from
those in invivomicroenvironments; indeed, this is a focusof
our ongoing research programs.
Interestingly, in agreement with previous studies
that reported an endothelial–pericyte coculture in-
crease in TEER values (1, 35), we showed that coculture
of endothelial cells and pericytes yielded higher TEER
values compared with an endothelial monolayer alone.
This finding confirms the importance of pericytes in
forming and maintaining the integrity of TJs (55, 56).
Findings showed that the use of CNS pericytes or
pericyte-conditioned medium regulated the localization
of claudin-5 and occludin in cultured endothelial cells,
strengthen barrier integrity and increasing the TEER of
endothelial cells in vitro (56, 57, 58). Other studies have
alsohighlightedabnormal expressionofTJs in endothelial
cells in pericyte-deficient mice (56, 59).
In the present study, the most effective culture simula-
tion for increasing TEER values and TJ protein expression
was the in-contact coculture model of endothelial cells
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Figure 9. Effect of Evans blue on a coculture BBB model to test for barrier integrity. Resistance was evaluated using EVOM. No
change in resistance values was recorded after the addition of Evans blue on a coculture BBB model, suggesting Evans blue did
not cross the barrier. P , 0.001.
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with astrocytes. Our findings confirm the cellular com-
munication and importance of astrocytes in inducing
barrier function andmaintaining barrier integrity.We also
showed that coculturing endothelial cells with pericytes
yielded higher TEER values compared with a monolayer
of endothelial cells, thus confirming the crosstalk of peri-
cytes in contributing to barrier tightness.
Moreover, this study isnovelwith respect to theaddition
ofhuman-derivedECMs,humansupplementation, and the
sole use of human brain–derived cells in various combina-
tions and in both contact and noncontact configurations.
Theunprecedentedly highTEER levels (.1000V) achieved
in vitro also endorse the use of such humanmodel systems.
We believe this increases knowledge on BBB biology and
closely mimics the in vivo situation, providing an effective
method for high-throughput screening of preclinical
nanoparticle-mediated therapeutic delivery to the brain
and investigating the transendothelial migration mech-
anism of cancer cells in brain metastasis.
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